Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitric Oxide in Pediatric Cardiopulmonary Bypass
NCT03455218Phase 3Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in platelet dysfunction (PFD) and inflammation comparing Nitric Oxide Arm with Placebo Arm (2 arms). Primary endpoints: Change in Platelet Count, 30 Day Mortality and 4 more. Started Apr 2018; status: completed.
02
Drugs
nitric oxide
03
Conditions
platelet dysfunction (PFD)inflammation
Beyond the preview
Go deeper on NCT03455218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03455218.